Gliclazide 60mg (MR)Tablets | Brand – Glidease-60MR | Manufacturer – Clide | Pack of 1×10 Tablets

Glidease-60MR is a fixed-dose combination of Gliclazide 60mg (Modified Release) used for the effective management of Type 2 Diabetes Mellitus. Manufactured by Clide, this combination helps achieve optimal blood glucose control through complementary mechanisms — improving insulin secretion and enhancing insulin sensitivity.

It is typically prescribed for adults with type 2 diabetes whose blood sugar levels are not adequately controlled by metformin alone or other monotherapies.

Key Benefits:

• Gliclazide MR stimulates insulin release from pancreatic β-cells

• Helps achieve better glycemic control with lower risk of weight gain

• Once-daily dosing improves patient compliance

Composition (per tablet):

• Gliclazide (Modified Release) – 60mg

Recommended Usage:

• Route: Oral

• Dosage: As prescribed by a Registered Medical Practitioner

• Preferably taken with meals to minimize gastrointestinal side effects

Storage Instructions:
Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of reach of children.

Regulatory Information:
This product requires a valid prescription for all retail orders.

Caution:

• Not recommended in patients with Type 1 diabetes or diabetic ketoacidosis

• Use with caution in patients with renal, hepatic, or cardiovascular impairment

• Monitor blood glucose and HbA1c levels regularly

• Risk of hypoglycemia, especially in elderly or undernourished patients